Available option
10mg
Lyophilised powder
- Strength
- 10mg
- Format
- Lyophilised powder
Bear Biotech catalogue
Cagrilintide
Long-acting amylin analogue research material
- Amylin signalling
- Satiety research
- Metabolic research
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Research overview
What is Cagrilintide?
Cagrilintide is a long-acting amylin analogue developed to investigate amylin-receptor signalling in appetite and metabolic research. Controlled human studies have made it one of the better-characterised investigational amylin compounds, including combination research with GLP-1 receptor agonists.
Phase 2 human trials; investigational
Research focus
Key research areas
Cagrilintide research: long-acting amylin signalling
Cagrilintide is an investigational long-acting amylin analogue. Human studies concern defined investigational formulations and controlled receptor-pathway protocols. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- Amylin signalling
- Satiety research
- Metabolic research
Representative primary research
Representative research
A randomised dose-finding phase-2 trial investigated a regulated cagrilintide product.
- Once-weekly cagrilintide for weight management: a randomised phase 2 trial ↗ The pharmaceutical trial product does not verify equivalence of catalogue research material.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- Cagrilintide
- Research category
- Long-acting amylin analogue research material
- Evidence position
- Phase 2 human trials; investigational
- Recorded formats
- Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
What does Cagrilintide's long-acting amylin design allow researchers to examine?
Its long-acting analogue design supports controlled study of amylin-receptor signalling over an extended observation window. Researchers measure specified satiety-related and metabolic physiology rather than assuming a general product effect.
Which endpoints have phase 2 Cagrilintide studies measured?
Phase 2 programmes used defined formulations and pre-specified appetite-related, metabolic and body-composition endpoints. Interpretation remains tied to those controlled protocols and study materials.
Why does investigational Cagrilintide evidence not establish equivalence for an unspecified vial?
Cagrilintide remains investigational, and its human evidence concerns defined trial formulations. Those findings do not establish the identity, quality or equivalence of generic research material.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.